First detection of the mcr-1 colistin resistance gene in Escherichia coli in Italy

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 5, 2016, Pages 3257-3258

  Cannatelli, Antonio ^a   Giani, Tommaso ^a   Antonelli, Alberto ^a,b   Principe, Luigi ^c   Luzzaro, Francesco ^c   Rossolini, Gian Maria ^a,b,d,e  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c A MANZONI HOSPITAL   (Italy)

^d CAREGGI UNIVERSITY HOSPITAL   (Italy)

^e IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; COLISTIN; COTRIMOXAZOLE; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT; ESCHERICHIA COLI PROTEIN; MCR-1 PROTEIN, E COLI;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BROTH DILUTION; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HUMAN; ITALY; LABORATORY TEST; LETTER; MCR 1 GENE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; DRUG EFFECT; ENZYMOLOGY; ESCHERICHIA COLI INFECTION; GENETICS; MICROBIOLOGY; PLASMID;

ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HUMANS; ITALY; PLASMIDS; RETROSPECTIVE STUDIES;

EID: 84964955478     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00246-16     Document Type: Letter

References (17)

1. Falagas ME, Kasiakou SK. 2005. Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin Infect Dis 40:1333-1341. http://dx.doi.org/10.1086/429323.
2. Monaco M, Giani T, Raffone M, Arena F, Garcia-Fernandez A, Pollini S; Network EuSCAPE-Italy Grundmann H, Pantosti A, Rossolini GM. 2014. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill 19:pii: 20939. http://dx.doi.org/10.2807 /1560-7917.ES2014.19.42.20939.
3. Giske CG. 2015. Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin. Clin Microbiol Infect 21:899-905. http://dx.doi.org/10.1016/j .cmi.2015.05.022.
4. Falagas ME, Rafailidis PI, Matthaiou DK. 2010. Resistance to polymyxins: mechanisms, frequency and treatment options. Drug Resist Updat 13:132-138. http://dx.doi.org/10.1016/j.drup.2010.05.002.
5. Olaitan AO, Morand S, Rolain JM. 2014. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol 5:643. http://dx.doi.org/10.3389/fmicb.2014.00643.
6. Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X, Yu LF, Gu D, Ren H, Chen X, Lv L, He D, Zhou H, Liang Z, Liu JH, Shen J. 2016. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16:161-168. http://dx.doi.org/10.1016/S1473-3099(15)00424-7.
7. Arcilla MS, van Hattem JM, Matamoros S, Melles DC, Penders J, de Jong MD, Schultsz C; COMBAT consortium. 2015. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis 16:147-149. http://dx.doi .org/10.1016/S1473-3099(15)00541-1.
8. Webb HE, Granier SA, Marault M, Millemann Y, den Bakker HC, Nightingale KK, Bugarel M, Ison SA, Scott HM, Loneragan GH. 2016. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis 16: 144-145. http://dx.doi.org/10.1016/S1473-3099(15)00538-1.
9. Tse H, Yuen KY. 2016. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis 16:145-146. http://dx.doi.org/10.1016/S1473-3099(15)00532-0.
10. Olaitan AO, Chabou S, Okdah L, Morand S, Rolain JM. 2015. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis 16:147. http://dx.doi.org/10.1016/S1473-3099(15)00540-X.
11. Falgenhauer L, Waezsada SE, Yao Y, Imirzalioglu C, Käsbohrer A, Roesler U, Michael GB, Schwarz S, Werner G, Kreienbrock L, Chakraborty T; RESET consortium. 7 January 2016. Colistin resistance gene mcr-1 in extended-spectrum β-lactamase-producing and carbapenemase- producing Gram-negative bacteria in Germany. Lancet Infect Dis http://dx.doi.org/10.1016/S1473-3099(16)00009-8.
12. Malhotra-Kumar S, Xavier BB, Das AJ, Lammens C, Hoang HT, Pham NT, Goossens H. 7 January 2016. Colistin-resistant Escherichia coli harbouring mcr-1 isolated from food animals in Hanoi, Vietnam. Lancet Infect Dis http://dx.doi.org/10.1016/S1473-3099(16)00014-1.
13. Poirel L, Kieffer N, Liassine N, Thanh D, Nordmann P. 2016. Plasmidmediated carbapenem and colistin resistance in a clinical isolate of Escherichia coli. Lancet Infect Dis 16:281. http://dx.doi.org/10.1016/S1473-3099(16)00006-2.
14. Hasman H, Hammerum AM, Hansen F, Hendriksen RS, Olesen B, Agersø Y, Zankari E, Leekitcharoenphon P, Stegger M, Kaas RS, Cavaco LM, Hansen DS, Aarestrup FM, Skov RL. 10 December 2015. Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveill. http://dx.doi.org/10.2807/1560-7917.ES.2015.20.49.30085.
15. Mulvey MR, Mataseje LF, Robertson J, Nash JHE, Boerlin P, Toye B, Irwin R, Melano RG. 2016. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis 16:289-290. http://dx.doi.org/10.1016/S1473-3099(16)00067-0.
16. Clinical and Laboratory Standards Institute. 2015. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 10th ed. CLSI document M07-A10. Clinical and Laboratory Standards Institute, Wayne, PA.
17. Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Karch Reeves HPR, Maiden MC, Ochman H, Achtman M. 2006. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 60:1136-1151. http://dx.doi.org/10.1111/j.1365-2958.2006.05172.x.